Rami Hannoush, Ph. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Lives in San Mateo, CA. منشور Rami Hannoush, Ph. View Rami Hannosh’s profile on LinkedIn, the world’s largest professional community. D. 11mo Report this comment Report Report. Rami Hannoush, Ph. Operating Status Active. ’s Post Rami Hannoush, Ph. . D. D. Currently teaching. D. D. Rami Hannoush General Partner, Mubadala Capital | Life sciences company creation | Chief Scientific Officer 10mo EditedUSA. , joined the Early Discovery Biochemistry department at Genentech in 2006 after completing his postdoctoral fellowship at Harvard and his Ph. com. Rami Hannoush, PhDPrincipal Scientist & Group Leader at Genentech. Here, we determined a crystal structure of human FZD7 CRD unexpectedly bound to a 24-carbon fatty acid. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. ’s Post Rami Hannoush, Ph. Rami Hannoush, Ph. Contact Email [email protected] Abstract Protein palmitoylation plays diverse roles in regulating the trafficking, stability, and activity of cellular proteins. Jennifer Stockdill, Wayne State University. D. Hannoush and Phil S. Rami Hannoush: Franklin Berger — Eli Lilly — DCVC Bio . A. D. The lipid-binding groove exhibits flexibility and spans both monomers,. D. D. The author has contributed to research in topics: Wnt signaling pathway & Frizzled. Rami Hannoush Manage my profile. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. The author has an hindex of 28, co-authored 68 publications receiving 2989 citations. ’s Post Rami Hannoush, Ph. Ribonucleic acids (RNA) are polymers of ribonucleotides linked together by 3',5'-phosphodiester linkages and play a prominent role in protein biosynthesis. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Symposium Sponsors. We cover Rami's new role at Versant, the founding story of. Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami. CSB 243: Biotechnology and Development of Therapeutics (Autumn)9 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA. D. Expand search. Corresponding author. Hannoush and Arenas-Ramirez, 2009; Martin and Cravatt, 2009) also showed efficient bioorthogonal labeling of fatty acyl-Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami Hannoush was treated to a caffeine-fueled review of the latest work UCSF’s Jim Wells had been doing on protein degradation — one of the hottest fields in drug development. D. ’s Post Rami Hannoush, Ph. Scroll Top. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 3mo Edited Report this post At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it provides a blueprint that. EpiBiologics’s CEO is Rami Hannoush Who are EpiBiologics key employees? Some of EpiBiologics key employees are Craig Lichtenstein Where is EpiBiologics located? EpiBiologics’s headquarters are located at 1900 Alameda De Las Pulgas Ste 250, San Mateo, California, 94403, United States How do I contact EpiBiologics? Rami Hannoush, Ph. D. Rami Hannoush, Ph. Rami Hannoush, Ph. The Frizzled (FZD) 7 receptor (FZD7) is enriched in LGR5 + intestinal stem cells and plays a critical role in their self-renewal. Healthcare VC | Life sciences company creation 6 dComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. She is taking over from co-founder Rami Hannoush, who will step into an advisory role. Jumi Shin, University of Toronto. D. Yet, how different Wnts achieve various levels of signaling activation through distinct domains on LRP6 remains elusive. Rami Hannoush, Ph. We cover Rami's new role at. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. The design of clickable fatty acid probes is based on the introduction of a small chemical tag (alkyne or azide) at the ω or methyl end of the fatty acid (Figure 2). Congratulations to our own Rami Hannoush, Principal Scientist, Early Discovery Biochemistry, for being one of ten to receive the U. He most recently served as a general partner at Mubadala Capital, building the firm's healthcare platform in the. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Introduction. Rami Hannoush has been working as a General Partner | US Ventures for Mubadala for 456 days. - Most recent fund raising on April 28, 2023 raised $30,030,000 in EquityAt last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Rami Hannoush . The advent of click chemistry has propelled the field of protein palmitoylation forward by providing specific, sensitive, rapid, and easy-to-handle methods for studying protein pal. We also report a crystal structure of human FZD5 CRD bound to C16:1 cis -Δ9 unsaturated fatty acid. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1y EditedRami Hannoush, Ph. When expanded it provides a list of search options that will switch the search inputs to match the. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Number of Current Jobs 2. View the profiles of professionals named "Rami D" on LinkedIn. 19th Ave New York, NY 95822, USA. Back. Today (2010) M. Founded in 2022 and led by CEO Dr. D. D. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). Rami Hannoush is the Chief Executive Officer (interim), President and a co-founder of EpiBiologics. This past Saturday, the Class of 2023…Biomarker interview with Rami Hannoush, Ph. Expand search. Rami Hannoush, PhDPrincipal Scientist & Group Leader at Genentech. PubMed Abstract: Regeneration of the adult intestinal epithelium is mediated by a pool of cycling stem cells, which are located at the base of the crypt, that express leucine-rich-repeat-containing G-protein-coupled receptor 5 (LGR5). D. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. D. Supplementary Figure 1 S5 . Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Healthcare VC | Life sciences company creation 2yThe 2020 Chemistry and Biology of Peptides Gordon Research Conference will showcase the most recent, cutting edge research in advancing peptides as tools, materials, and therapeutics. Supplementary information. Rami Hannoush: Chemical tools to perturb and image Wnt signaling: Danica Galonic Fujimori: 3/15/12: Harmit Malik, Fred Hutchinson Cancer Center: Genetic conflicts: the usual suspects and beyond: John Gross: 4/5/12: Ian Wilson, Scripps: Broad neutralization of HIV and influenza viruses: Bob Stroud:It started with a cup of coffee and a slow burning desire to go early and long in the biotech creation business. Back. chembiol. rami@gene. Background. Verified email at post. Inventors: Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark Solloway, Yan Wu METHODS AND COMPOSITIONS FOR MODULATING THE Wnt PATHWAY Protein palmitoylation plays diverse roles in regulating the trafficking, stability, and activity of cellular proteins. D. Clickable fatty acids coupled with in situ proximity ligation allow visualization of Wnt as it trafficks through the secretory pathway, defining roles for palmitoylation and glycosylation in. 9:40 am - 10:05 am: Dinesh Patel (Protagonist Therapeutics Inc. Beachy. D. It’s been a terrific two days at #jpm2023, meeting new talent and connecting with friends in pharma and the VC world. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1 mes Denunciar esta publicación Denunciar Denunciar. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Supplementary Text and Figures. Rami N. “Jim and I have known each other for the past 15 years through Genentech collaborations. Both structures reveal a dimeric arrangement of the CRD. “Dysregulation of normal cellular differentiation processes can alter normal cell biology leading to tumor formation and progression,” said Dr. He brings a unique blend of investment experience and deep drug discovery expertise to our company creation efforts. … | 79 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Healthcare VC | Life sciences company creation 1y 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of patients with unmet medical needs. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. Hannoush is a general partner at Mubadala Capital, the financial investment arm of the Sovereign Wealth Fund Mubadala. Back Submit. The advent of click chemistry has propelled the field of protein palmitoylation forward by providing specific,. Genentech Inc. Mubadala Capital Ventures General Partner Sep 2021. Rami Hannoush: Chemical tools to perturb and image Wnt signaling: Danica Galonic Fujimori: 3/15/12: Harmit Malik, Fred Hutchinson Cancer Center: Genetic conflicts: the usual suspects and beyond: John Gross: 4/5/12: Ian Wilson, Scripps: Broad neutralization of HIV and influenza viruses: Bob Stroud:It started with a cup of coffee and a slow burning desire to go early and long in the biotech creation business. EpiBiologics - a biotechnology company advancing a next-generation antibody-based protein degradation platform and pipeline for membrane and extracellular drug targets - recently announced the company brought the total series A round to $73 million with the addition of $23 million from new investors Digitalis Ventures, Taiho Ventures, and existing investor Codon Capital. Rami Hannoush 5d · Edited Report this post Report Report. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. Rami Hannoush’s Post Rami Hannoush General Partner, Mubadala Capital | Healthcare VC | Life sciences company creation 4d Report this post. … | 80 comments on LinkedInAt last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Fully funded PhD position in my group to investigate the mechanisms of cartilage regeneration Defining the molecular drivers of cartilage regeneration at…Biomarker interview with Rami Hannoush, Ph. D. The company intends to use the funds to advance the lead program toward clinical development and drive additional programs into drug discovery. San Mateo, CA. 11mo Report this comment Report Report. Schneider, National Cancer Institute – Center for Cancer Research. Rami Hannoush General Partner, Mubadala Capital | Life sciences company creation | Chief Scientific Officer 1y EditedRami Hannoush, Ph. Back. Noah Z. Auron was founded by a world class team of physicians and scientists with proven expertise in bringing effective differentiation therapies to patients. Three years, 70 Saturdays, 600 hours. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. D. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1mo Report this post Report Report. Schneider, National Cancer Institute – Center for Cancer Research. D. PMID: 24292069 DOI: 10. and Jim Wells to the portfolio. D. This is a mechanism that's been conserved throughout the animal kingdom,” explains Rami Hannoush, interim CEO and co-founder of EpiBiologics. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Anwesha Dey,4 Rami N. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 7 شهر تم التحريرRami Hannoush, Ph. D. Rami Hannoush, Ph. ACS Chemical Biology editors highlight articles from Volume 4, Issue 7, and speak with authors Rami Hannoush and Domagoj Vucic. Unparalleled access to new data & case studies from globally recognized speakers across the entire landscape of oligonucleotides, peptides, mRNA, genome. Born on September 20th, 1976 (47 years old)Rami Hannoush, Ph. Rami Hannoush has been working as a General Partner | US Ventures for Mubadala for 456 days. 3 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94080; hannoush. cbpa. Biomarker interview with Rami Hannoush, Ph. Dynasore inhibits cell proliferation of OS in vitro. D. Founded in 2022 and led by CEO Dr. Rami N Hannoush 1 Affiliation 1 Department of Early Discovery Biochemistry, Genentech, Inc. According to LinkedIn Rami Hannoush started working on 2006, then the employee has changed 9 companies and 12 jobs. degree at McGill University. Back. EpiBiologics - a biotechnology company advancing a next-generation antibody-based protein degradation platform and pipeline for membrane and extracellular drug targets - recently announced the company brought the total series A round to $73 million with the addition of $23 million from new investors Digitalis Ventures, Taiho. The WNT-FZD (W i n gless/In t 1-F ri z zle d) signaling system has a prevalent role in physiology during adulthood. Rami Nabil Hannoush, Rami Hannoush, Ramin Hannoush. H. See the complete. com. Hannoush, 5Wayne J. ’s Post Rami Hannoush, Ph. D. Rami most recently served as a general partner at Mubadala Capital, building the firm’s healthcare platform in the U. Rami Hannoush serves as Venture Partner at Versant Ventures. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Discover Digital Health profiles, team, funding and valuation with HealthTech Alpha. Expand search. The Frizzled (FZD) 7 receptor (FZD7) is enriched in LGR5 + intestinal stem cells and plays a. ’s Post Rami Hannoush, Ph. There is no recent news or activity for this profile. Synthetic therapeutic peptides: science and market. 120. , 1 DNA Way, South San Francisco, CA 94080, USA. President’s Welcome. … | 76 comments on LinkedInRami Hannoush, Ph. Rami Hannoush, Department of Early Discovery Biochemistry, Genentech. Developing tool ligands that target individual LRP6 domains could help elucidate the mechanism of. D. The American Peptide Society, APS, a nonprofit scientific and educational organization founded in 1990, provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. D. EpiBiologics's CEO is Rami Hannoush What does EpiBiologics do? Founded in 2022, EpiBiologics is a biotechnology company with a focus on antibody-based protein degradation. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Expand search. 5 From the Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden, the Faculty of Science, Institute of Experimental Biology, Masaryk. Rami Hannoush, Ph. They found a peptide that converts the caspase to its inactive state—the zymogen—and traps it there, a bit like a wheel clamp. Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, United States. It has been an incredible journey building this company. com. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 6mo Edited Report this post Great chat with. Lawyers - Get Listed Now! Get a free. Baran . degree at. 1392 Abstract Wnts are secreted palmitoylated glycoproteins that are important in embryonic development and human cancers. , Partner at Apollo Health Ventures, will join the Company as Board observers. We cover Rami's new role at Versant, the founding story of. Expand search. Rami Hannoush has 2 current jobs as General Partner at Mubadala Capital Ventures and Co-Founder at EpiBiologics. The site facilitates. D. Rami Hannoush, Ph. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Rami Hannoush, Ph. One of many physiological findings about lipid–protein interaction is that lipid modifications regulate some proteins generated by cancer genes, says Rami Hannoush, a chemical biologist at the. Rami N Hannoush is part of Stanford Profiles, official site for faculty, postdocs, students and staff information (Expertise, Bio, Research, Publications, and more). 388. Symposium Sponsors. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1y 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of. Last Funding Type Series A. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. D. D. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. com; PMID: 21964784 DOI: 10. D. 5 From the Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden, the Faculty of Science, Institute of Experimental. Founders James Wells, Rami Hannoush. D. D. D. , 1 DNA Way, South San Francisco, CA 94080, USA. Mar 22, 2023. Back. Funds will also. Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. Download Record Provide Feedback. D. Auron expands its leadership team with the appointments of David Millan, Ph. ’s Post Rami Hannoush, Ph. 025. Xinxin Gao, Xinxin Gao. Rami. D. … | 77 comments on LinkedInRami Hannoush, Ph. D General Information. rami@gene. com. ’s Post Rami Hannoush, Ph. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 6d EditedRami Hannoush, Ph. Lotte Simonsen, Novo Nordisk. Healthcare VC | Life sciences company creation. 1007/978-1-4939-9532-5_17 Abstract Wnts are lipid-modified proteins that regulate stem cell signaling via Frizzled receptors on the cell surface. D. hannoush. Connect Hamed Alemohammad Greater Boston. 1618293114 Abstract Frizzled (FZD) receptors mediate Wnt signaling in diverse processes ranging from bone growth to stem cell activity. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. San Mateo, California, United States 4K followers 500+ connections See your mutual connections Join to follow Versant Ventures Harvard University. Rami. D. View the profiles of professionals named. D. Rami Hannoush, Ph. Rami Hannoush, Ph. hannoush. com. Burns, Irina N. Rami Hannoush, education was also an escape. D. Congrats Juvena Therapeutics for the series A raise. English. PMID: 30530496 PMCID: PMC6333880 Rami Hannoush, interim-CEO, said, “Since launching the company, the team at EpiBiologics has been able to further validate and industrialize the EpiTAC platform, creating a fit-for-purpose atlas of degraders. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. D. Mr. D. Back. D. . Our mission is to partner with visionary founders building enduring technology companies, and support them with Mubadala’s global scale, resources. Genentech, McGill, Harvard, Versant Ventures. Baig et al. 05. D. D. Edit Recent News Section. When expanded it provides a list of search options that will switch the search inputs to match the. However, the specificity of the interaction between mammalian WNT and FZD proteins and the subsequent signaling cascade downstream. Question: Add details. Join to view full profile. D. D. Expand search. Back. Rami N. Supplementary Figure 3 S6Taught/moderated by Ryan Watts, founder/CEO of Denali Therapeutics, and Rami Hannoush, former senior scientist at Genentech and now a partner at Mubadala, who bring in former / current colleagues to introduce each of the major functions (e. D. ’s Post Rami Hannoush, Ph. We cover Rami's new role at Versant, the founding story of. . Rami Hannoush, Ph. By Ron Leuty – Senior Reporter, San Francisco Business Times. Previously he was Pro-Rector for. D. Healthcare VC | Life sciences company creation 6 TageThank you Ayman, Alaa, and Rami for your trust and support! Could not have asked for better partners. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Back. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Back. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Back [email protected] last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Tracking Wnts throughout such processes will present a challenge, but might be facilitated by emerging techniques, such as a method for metabolic labeling of palmitoylated Wnts presented by Rami Hannoush (Genentech, San Francisco, USA) . , as Chief Scientific Officer, Thomas Graeber, Ph. Back Submit. EpiBiologics, Inc. October 7-10, 2018 | Emerging Data on the Role of Wnt Biology in Cancer | 4 WEDNESDAY, OCTOBER 10 7:15 am Breakfast 9:00 am SESSION 8: Emerging Applications for Wnt Signaling in CancerRami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Healthcare VC | Life sciences company creation 1wRami Hannoush, 45. Rami Hannoush, PhD. Genentech veteran Rami Hannoush, UCSF professor Jim Wells team up to score $50M for protein degradation startup EpiBiologics - San Francisco Business TimesThere are 8 professionals named "Rami D", who use LinkedIn to exchange information, ideas, and opportunities. Joel P. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. ” Prior to EpiBiologics, Dr. Mr. . Journal of the American Chemical Society 2009, 131 (26) , 9172-9173. References [1] J. Less time bookkeeping means more time to pursue your. com. Previous affiliations of Rami N. I had the pleasure to join Rob Faulkner and Soo. Back. ’s Post Rami Hannoush, Ph. Genentech, McGill, Harvard, Versant Ventures. His current role includes leading interdisciplinary teams in lead discovery and research biology, with the overarching goal of developing therapeutics for the. 10. Citizen and Immigration Services 2019 Outstanding Americans by. D. His current role includes leading interdisciplinary teams in lead discovery and research biology, with the overarching goal of developing therapeutics. Rami Hannoush’s Post. ’s Post Rami Hannoush, Ph. Rami N. . ’s Post Rami Hannoush, Ph. We cover Rami's new role at. Rami Hannoush, Ph. San Mateo, California, United States 4K followers 500+ connections See your mutual connections Join to follow Versant Ventures Harvard University Personal Website About -. Hannoush (hannoush. Rami Hannoush has 2 current jobs as General Partner at Mubadala Capital Ventures and Co-Founder at EpiBiologics. Rami Hannoush, Ph. Congrats Cameron! Like Reply 1 Reaction. D. Rami Hannoush, Ph. edu - Homepage. Rami Hannoush, Ph. Jobs. ’s Post Rami Hannoush, Ph. Beitrag von Rami Hannoush, Ph. Mubadala Capital Ventures General Partner Sep 2021. Rami Hannoush has 2 current jobs as General Partner at Mubadala Capital Ventures and Co-Founder at EpiBiologics. Owing to a lack of robust detection technologies, the mechanisms by. Simon Hansen 1 , Yingnan Zhang 1 , Sunhee Hwang 1 , Ahmad Nabhan 2 , Wanqing Li 1 , Jakob Fuhrmann 1 , Yvonne Kschonsak 3 , Lijuan Zhou 1 , Aaron H Nile 1 , Xinxin Gao 1 , Robert Piskol 3 , Felipe de Sousa E Melo 3 , Frederic J de Sauvage 3 , Rami N Hannoush 1 Contact Rami directly. . ”Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. , Partner at Mubadala Capital, and Dr. D. D. EpiBiologics is part of the Business Services industry, and located in California, United States. . Hannoush joined the Early Discovery Biochemistry department at Genentech in 2006 after completing his postdoctoral fellowship at Harvard and his Ph. D. Rami Hannoush, Ph. Rami N Hannoush Adjunct Professor, Chemical and Systems Biology Operations Print Profile Email Profile Bio Bio Professional Contact. Rami N. Rami Hannoush, Genentech, South San Francisco, USA 5:25 pm General Discussion, Day 2 Wrap-Up 6:00 pm Reception, dinner . Scalable Total Synthesis and Biological Evaluation of Haouamine A and Its Atropisomer. Hannoush [email protected] Department of Early Discovery Biochemistry, Genentech, Inc. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures.